Home > Analytics > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
Intrinsic Value | Fundamental Analysis

BOM : 524412     NSE : AAREYDRUGS    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Downward
Price Momentum : Upward
Pledged Shares : None or < 25%
Sep 30,2026
Price(EOD): ₹ 102.47
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Trading
MCap: ₹ 316.63 Cr
Value of ₹ 1 Lac invested in AAREY DRUGS & PHARMACEUTICALS
on Sep 29,2021 (price: ₹ 37.15)

₹ 1 L

→

₹ 2.76 L

1W : -2.3% 1M : 11.8% 1Y : 27.8%
COMMUNITY POLL
for AAREY DRUGS & PHARMACEUTICALS
Please provide your vote to see the results
AAREY DRUGS & PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
AAREY DRUGS & PHARMACEUTICALS -2.3% 11.8% 27.8%
ADANI ENTERPRISES -0.8% -6.3% 9.1%
PREMIER ENERGIES -4% -13.8% -10.4%
ADITYA INFOTECH -0.3% 6.7% 167.3%
AEGIS LOGISTICS -7.4% 0.9% 67.4%
REDINGTON 1.1% 10.8% 41.9%
RRP SEMICONDUCTOR -3.9% -19% 4830.5%
HONASA CONSUMER -9% -6.3% 54.9%
LLOYDS ENTERPRISES 6.9% 8.4% 14.6%

FUNDAMENTAL ANALYSIS OF AAREY DRUGS & PHARMACEUTICALS

 
Fundamentals Score
[ Q(TTM): Jun2026, Y: Mar2025
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]



VALUATION OF AAREY DRUGS & PHARMACEUTICALS

 
Valuation Score
[As on : Sep 30,2026 ]

Ratio Standalone
P/E
P/B
P/S
75.76
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 4.18 Cr
[Latest Qtr - Jun2026 - Standalone Results ]

2.33
P/B Calculated based on Book Value of Rs 135.97 Cr
[Latest Year - Mar2025 - Standalone Results ]

0.76
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Jun2026 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 71% undervalued companies ! Discover More →

FAIR VALUE OF AAREY DRUGS & PHARMACEUTICALS

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
NA
419%
335%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF AAREY DRUGS & PHARMACEUTICALS


Insights 💡 AAREYDRUGS is one of the top 52% companies with bullish price momentum currently! Discover More →

AAREY DRUGS & PHARMACEUTICALS vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF AAREY DRUGS & PHARMACEUTICALS

Year Debt/Equity ratio
Standalone Consolidated
2025
2024
2023
Avg_3yrs
0.26
0.24
0.33
0.28
-
-
-
-
[Last Annual Data : Mar2025]
Financial Ratios →

PLEDGED PROMOTER SHARES OF AAREY DRUGS & PHARMACEUTICALS

Pledged Promoter Shares
0 %
As on : Jun2026

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF AAREY DRUGS & PHARMACEUTICALS

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-76.45%
-69.45%
-59.69%
-34.23%
-56.34%
-22.09%
-70.14%
-25.31%
QtrlyTrend
-8
Latest Qtr: Jun2026
Quarterly Result Analysis →


AAREY DRUGS & PHARMACEUTICALS related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about AAREY DRUGS & PHARMACEUTICALS


Is AAREY DRUGS & PHARMACEUTICALS good for long term investment?

As on Sep 30,2026, the Fundamentals of AAREY DRUGS & PHARMACEUTICALS look Poor and hence it may not be good for long term investment ! See Financial Performance of AAREY DRUGS & PHARMACEUTICALS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is AAREY DRUGS & PHARMACEUTICALS UnderValued or OverValued?

As on Sep 30,2026, AAREY DRUGS & PHARMACEUTICALS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of AAREY DRUGS & PHARMACEUTICALS ?

As on Sep 30,2026, the Intrinsic Value of AAREY DRUGS & PHARMACEUTICALS is Rs. 21.65 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. -2.66
Fair Value [Median EV / Sales Model] : Rs. 19.76
Fair Value [Median Price / Sales Model] : Rs. 23.54
Estimated Median Fair Value of AAREY DRUGS & PHARMACEUTICALS : Rs. 21.65

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is AAREY DRUGS & PHARMACEUTICALS trading at a Premium or Discount?

As on Sep 30,2026, AAREY DRUGS & PHARMACEUTICALS is trading at a Premium of 373% based on the estimates of Median Intrinsic Value!